224 related articles for article (PubMed ID: 17316587)
21. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
[TBL] [Abstract][Full Text] [Related]
22. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
23. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
24. Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 2():25-39. PubMed ID: 18830862
[TBL] [Abstract][Full Text] [Related]
25. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
26. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
[TBL] [Abstract][Full Text] [Related]
27. Hprt mutant frequency and p53 gene status in mice chronically exposed by inhalation to benzene.
Albertini RJ; Judice SA; Recio L; Walker VE
Chem Biol Interact; 2010 Mar; 184(1-2):77-85. PubMed ID: 20035728
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model.
Fred C; Törnqvist M; Granath F
Cancer Res; 2008 Oct; 68(19):8014-21. PubMed ID: 18829559
[TBL] [Abstract][Full Text] [Related]
29. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of effects from repeated inhalation exposure of F344 rats to high concentrations of propylene.
Pottenger LH; Malley LA; Bogdanffy MS; Donner EM; Upton PB; Li Y; Walker VE; Harkema JR; Banton MI; Swenberg JA
Toxicol Sci; 2007 Jun; 97(2):336-47. PubMed ID: 17341482
[TBL] [Abstract][Full Text] [Related]
31. Perfluorooctanoic acid: relationship between repeated inhalation exposures and plasma PFOA concentration in the rat.
Hinderliter PM; DeLorme MP; Kennedy GL
Toxicology; 2006 May; 222(1-2):80-5. PubMed ID: 16513238
[TBL] [Abstract][Full Text] [Related]
32. Studies of thioguanine-resistant lymphocytes induced by in vivo irradiation of mice.
Jones IM; Burkhart-Schultz K; Strout CL; Nelson DO
Environ Mol Mutagen; 2008 Jun; 49(5):343-50. PubMed ID: 18418873
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of hprt mutant lymphocytes from 1, 3-butadiene-exposed workers.
Ma H; Wood TG; Ammenheuser MM; Rosenblatt JI; Ward JB
Environ Mol Mutagen; 2000; 36(1):59-71. PubMed ID: 10918361
[TBL] [Abstract][Full Text] [Related]
35. Inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice.
Charest-Tardif G; Tardif R; Krishnan K
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):63-9. PubMed ID: 16085205
[TBL] [Abstract][Full Text] [Related]
36. Genotoxicity of intermittent co-exposure to benzene and toluene in male CD-1 mice.
Wetmore BA; Struve MF; Gao P; Sharma S; Allison N; Roberts KC; Letinski DJ; Nicolich MJ; Bird MG; Dorman DC
Chem Biol Interact; 2008 Jun; 173(3):166-78. PubMed ID: 18455711
[TBL] [Abstract][Full Text] [Related]
37. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide.
Walker VE; Wu KY; Upton PB; Ranasinghe A; Scheller N; Cho MH; Vergnes JS; Skopek TR; Swenberg JA
Carcinogenesis; 2000 Sep; 21(9):1661-9. PubMed ID: 10964097
[TBL] [Abstract][Full Text] [Related]
39. Disposition of inhaled isobutene in F344/N rats.
Henderson RF; Sabourin PJ; Bechtold WE; Steinberg B; Chang IY
Toxicol Appl Pharmacol; 1993 Nov; 123(1):50-61. PubMed ID: 8236261
[TBL] [Abstract][Full Text] [Related]
40. Biotransformation of trans-1,1,1,3-tetrafluoropropene (HFO-1234ze).
Schuster P; Bertermann R; Rusch GM; Dekant W
Toxicol Appl Pharmacol; 2009 Sep; 239(3):215-23. PubMed ID: 19573548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
